MYDA Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,000
Closed -$273K 118
2019
Q4
$273K Buy
+7,000
New +$273K 0.12% 69